Variables | UBC (n = 67) | Control (n = 61) | p-value |
---|---|---|---|
Age (years) | 63.4 ± 10.7 | 62.9 ± 10.2 | 0.815 |
Sex (%) | |||
 Female | 49 (73.1%) | 43 (70.5%) | 0.844 |
 Male | 18 (26.9%) | 18 (29.5.2%) | |
BMI (kg/m2) | 26.7 ± 3.4 | 25.7 ± 3.3 | 0.107 |
Smoker, n (%) | 18 (26.9%) | 20 (32.8%) | 0.562 |
Operative level, n (%) | |||
 L3-4 | 8 (11.9%) | 10 (16.4%) | 0.769 |
 L4-5 | 28(41.8%) | 24 (39.3%) | |
 L5-S1 | 31(46.3%) | 27 (44.3%) | |
Schizas classification, n (%) | |||
 C | 48 (71.6%) | 40 (65.6%) | 0.567 |
 D | 19 (28.4%) | 21 (34.4%) | |
 Duration of disease (days) | 36.6 ± 8.5 | 36.4 ± 8.3 | 0.889 |
Comorbidity | |||
 Hypertension | 12 (17.9%) | 16 (26.2%) | 0.289 |
 Cardiopathy | 16 (23.9%) | 19 (31.1%) | |
 Lung disease | 12 (17.9%) | 16 (26.2%) | |
 Follow-up (months) | 26.2 ± 1.6 | 25.6 ± 2.1 | 0.097 |